An interaction between apolipoprotein E and TERE1 with a possible association with bladder tumor formation

Journal of Cellular Biochemistry

Volumn 95, Issue 2, 2005, Pages 419-428

  McGarvey, Terence W ^a,b   Nguyen, Trang B ^b   Malkowicz, S Bruce ^a,b,c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Nine Penn Towers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; COMPLEMENTARY DNA; MITOGEN ACTIVATED PROTEIN KINASE;

AFFINITY CHROMATOGRAPHY; ANIMAL TISSUE; ARTICLE; BLADDER MUCOSA; BLADDER TUMOR; CARBOXY TERMINAL SEQUENCE; FIBROBLAST; GENETIC TRANSFECTION; GROWTH REGULATION; HUMAN; HUMAN CELL; KIDNEY CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; TWO HYBRID SYSTEM;

APOLIPOPROTEINS E; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; HUMANS; PROTEIN BINDING; PROTEINS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

BACTERIA (MICROORGANISMS);

EID: 26444593995     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20432     Document Type: Article

References (36)

1. Adachi H, Igawa M, Shiina H, Urakami S, Shigeno K, Hino O. 2003. Human bladder tumors with 2-hit mutations of tumor suppressor gene TSC1 and decreased expression of p27. J Urol 170:601-614.
2. Aveyard JS, Skilleter A, Habuchi T, Knowles MA. 1999. Somatic mutation of PTEN in bladder carcinoma. Br J Cancer 80:904-908.
3. Bohm M, Wieland I, Schmidt C, Rubben H, Allhoff EP. 2002. Loss of heterozygosity on chromosome 5p13-12 predicts adverse prognosis in advanced bladder cancer independent of tumor stage and grade. J Urol 168:2655-2658.
4. Catalona WJ. 1988. Urothelial tumors of the urinary tract. In: Walsh PC et al., editors. Campell's urology. 6th edn. Philadelphia: Saunders; pp. 1094-1158.
5. Chan MW, Chan LW, Tang NL, Lo KW, Tong JH, Chan AW, Cheung HY, Wong WS, Chan PS, Lai FM, To KF. 2003. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients. Int J Cancer 104:611-616.
6. Chang LL, Yeh WT, Yang SY, Wu WJ, Huang CH. 2003. Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer. J Urol 170:595-600.
7. Chen G, Paka L, Kako Y, Singhal P, Duan W, Pillarisetti S. 2001. A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem 276:49142-49147.
8. Do Carmo S, Seguin D, Milne R, Rassart E. 2002. Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 277:5514-5523.
9. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M. 2002. Urinary bladder. In: American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th edn. New York, NY: Springer; pp. 335-340.
10. Hass S, Fresser F, Kochl S, Beyreuther K, Utermann G, Baier G. 1998. Physical interaction of ApoE with amyloid precursor protein independent of the amyloid A beta region in vitro. J Biol Chem 273:13892-13897.
11. Ho YY, Al-Haideri M, Mazzone T, Vogel T, Presley JF, Sturley SL, Deckelbaum RJ. 2000. Endogenously expressed apolipoprotein E has different effects on cell lipid metabolism as compared to exogenous apolipoprotein E carried on triglyceride-rich particles. Biochemistry 39:4746-4754.
12. Ho YY, Deckelbaum RJ, Chen Y, Vogel T, Talmage DA. 2001. Apolipoprotein E inhibits serum-stimulated cell proliferation and enhances serum-independent cell proliferation. J Biol Chem 276:43455-43462.
13. Hoque MO, Lee CC, Cairns P, Schoenberg M, Sidransky D. 2003. Genome-wide genetic characterization of bladder cancer: A comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res 63:2216-2222.
14. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ. 2000. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60:6281-6287.
15. Hussain SA, Ganesan R, Hiller L, Murray PG, el-Magraby MM, Young L, James ND. 2003. Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. Br J Cancer 88:586-592.
16. Ishigami M, Swertfeger DK, Granholm NA, Hui DY. 1998. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J Biol Chem 273: 20156-20161.
17. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003. Cancer statistics, 2003. CA Cancer J Clin 53:5-26.
18. Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, McConkey DJ, Dinney CP. 2003. Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin Cancer Res 9:2786-2797.
19. Koo SH, Kwon KC, Ihm CH, Jeon YM, Park JW, Sul CK. 1999. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. Cancer Genet Cytogenet 110:87-93.
20. Law GL, McGuinness MP, Linder CC, Griswold MD. 1997. Expression of apolipoprotein E mRNA in the epithelium and interstitium of the testis and the epididymis. J Androl 18:32-42.
21. Li X, Su RT, Hsu HT, Sze H. 1998. The molecular chaperone calnexin associates with the vacuolar H(+)-ATPase from oat seedlings. Plant 10:119-130.
22. Lu ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z, Dalbagni G, Pohar KS, Yu G, Cordon-Cardo C. 2002. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clin Cancer Res 8:171-179.
23. Malkowicz SB, Wein AJ. 1994. Adult genitourinary cancer. In: Hanno PM, Wein AJ, editors. Cliical Manual of Urology. 2nd edn. NY: McGraw Hill; pp. 419-477.
24. McGarvey TW, Nguyen T, Tomaszewski JE, Monson FC, Malkowicz SB. 2001. Isolation and characterization of the TERE1 gene, a gene down-regulated in transitional cell carcinoma of the bladder. Oncogene 20:1042-1051.
25. McGarvey TW, Nguyen T, Puthiyaveettil R, Tomaszewski JE, Malkowicz SB. 2003. TERE1, a novel gene affecting growth regulation in prostate carcinoma. Prostate 54: 144-155.
26. Ohnishi S, Ohnami S, Laub F, Aoki K, Suzuki K, Kanai Y, Haga K, Asaka M, Ramirez F, Yoshida T. 2003. Down-regulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun 308: 251-256.
27. Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, Bubley G, Balk S, Loda M. 2003. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res 1:707-715.
28. Shaywitz AJ, Dove SL, Kornhauser JM, Hochschild A, Greenberg ME. 2000. Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein. Mol Cell Biol 20:9409-9422.
29. Sun W, Herrera GA. 2002. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma. Hum Pathol 33:996-1000.
30. Swiatkowski S, Seifert HH, Steinhoff C, Prior A, Thievessen I, Schliess F, Schulz WA. 2003. Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. Exp Cell Res 282:48-57.
31. Tonetti M, Sturla L, Bisso A, Benatti U, De Flora A. 1996. Synthesis of GDP-L-fucose by the human FX protein. J Biol Chem 27:27274-27279.
32. Urist MJ, Di Como CJ, Lu ML, Charytonowicz E, Verbel D, Crum CP, Ince TA, McKeon FD, Cordon-Cardo C. 2002. Loss of p63 expression is associated with tumor progression in bladder cancer. Am J Pathol 161:1199-1206.
33. Utku N, Heinemann T, Tullius SG, Bulwin GC, Beinke S, Blumberg RS, Beato F, Randall J, Kojima R, Busconi L, Robertson ES, Schulein R, Volk HD, Milford EL, Gullans SR. 1998. Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Immunity 9:509-518.
34. Venanzoni MC, Giunta S, Muraro GB, Storari L, Crescini C, Mazzucchelli R, Montironi R, Seth A. 2003. Apolipoprotein E expression in localized prostate cancers. Int J Oncol 22:779-786.
35. Vogel T, Guo NH, Guy R, Drezlich N, Krutzsch HC, Blake DA, Panet A, Roberts DD. 1994. Apolipoprotein E: A potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem 54:299-308.
36. Wu W, Shu X, Hovsepyan H, Mosteller RD, Broek D. 2003. VEGF receptor expression and signaling in human bladder tumors. Oncogene 22:3361-3370.